Role of the Streptococcus mutans CRISPR-Cas systems in immunity and cell physiology
- PMID: 25488301
- PMCID: PMC4334182
- DOI: 10.1128/JB.02333-14
Role of the Streptococcus mutans CRISPR-Cas systems in immunity and cell physiology
Abstract
CRISPR-Cas systems provide adaptive microbial immunity against invading viruses and plasmids. The cariogenic bacterium Streptococcus mutans UA159 has two CRISPR-Cas systems: CRISPR1 (type II-A) and CRISPR2 (type I-C) with several spacers from both CRISPR cassettes matching sequences of phage M102 or genomic sequences of other S. mutans. The deletion of the cas genes of CRISPR1 (ΔC1S), CRISPR2 (ΔC2E), or both CRISPR1+2 (ΔC1SC2E) or the removal of spacers 2 and 3 (ΔCR1SP13E) in S. mutans UA159 did not affect phage sensitivity when challenged with virulent phage M102. Using plasmid transformation experiments, we demonstrated that the CRISPR1-Cas system inhibits transformation of S. mutans by the plasmids matching the spacers 2 and 3. Functional analysis of the cas deletion mutants revealed that in addition to a role in plasmid targeting, both CRISPR systems also contribute to the regulation of bacterial physiology in S. mutans. Compared to wild-type cells, the ΔC1S strain displayed diminished growth under cell membrane and oxidative stress, enhanced growth under low pH, and had reduced survival under heat shock and DNA-damaging conditions, whereas the ΔC2E strain exhibited increased sensitivity to heat shock. Transcriptional analysis revealed that the two-component signal transduction system VicR/K differentially modulates expression of cas genes within CRISPR-Cas systems, suggesting that VicR/K might coordinate the expression of two CRISPR-Cas systems. Collectively, we provide in vivo evidence that the type II-A CRISPR-Cas system of S. mutans may be targeted to manipulate its stress response and to influence the host to control the uptake and dissemination of antibiotic resistance genes.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
Figures
Similar articles
-
CcpA and CodY Regulate CRISPR-Cas System of Streptococcus mutans.Microbiol Spectr. 2023 Aug 17;11(4):e0182623. doi: 10.1128/spectrum.01826-23. Epub 2023 Jun 27. Microbiol Spectr. 2023. PMID: 37367300 Free PMC article.
-
Analysis of CRISPR in Streptococcus mutans suggests frequent occurrence of acquired immunity against infection by M102-like bacteriophages.Microbiology (Reading). 2009 Jun;155(Pt 6):1966-1976. doi: 10.1099/mic.0.027508-0. Epub 2009 Apr 21. Microbiology (Reading). 2009. PMID: 19383692
-
Characterization of a Type II-A CRISPR-Cas System in Streptococcus mutans.mSphere. 2020 Jun 24;5(3):e00235-20. doi: 10.1128/mSphere.00235-20. mSphere. 2020. PMID: 32581075 Free PMC article.
-
Genomic impact of CRISPR immunization against bacteriophages.Biochem Soc Trans. 2013 Dec;41(6):1383-91. doi: 10.1042/BST20130160. Biochem Soc Trans. 2013. PMID: 24256225 Review.
-
CRISPR-Cas systems: Prokaryotes upgrade to adaptive immunity.Mol Cell. 2014 Apr 24;54(2):234-44. doi: 10.1016/j.molcel.2014.03.011. Mol Cell. 2014. PMID: 24766887 Free PMC article. Review.
Cited by
-
Human saliva modifies growth, biofilm architecture, and competitive behaviors of oral streptococci.mSphere. 2024 Feb 28;9(2):e0077123. doi: 10.1128/msphere.00771-23. Epub 2024 Feb 6. mSphere. 2024. PMID: 38319113 Free PMC article.
-
Human Saliva Modifies Growth, Biofilm Architecture and Competitive Behaviors of Oral Streptococci.bioRxiv [Preprint]. 2023 Aug 21:2023.08.21.554151. doi: 10.1101/2023.08.21.554151. bioRxiv. 2023. PMID: 37662325 Free PMC article. Updated. Preprint.
-
CcpA and CodY Regulate CRISPR-Cas System of Streptococcus mutans.Microbiol Spectr. 2023 Aug 17;11(4):e0182623. doi: 10.1128/spectrum.01826-23. Epub 2023 Jun 27. Microbiol Spectr. 2023. PMID: 37367300 Free PMC article.
-
Mechanisms regulating the CRISPR-Cas systems.Front Microbiol. 2023 Feb 28;14:1060337. doi: 10.3389/fmicb.2023.1060337. eCollection 2023. Front Microbiol. 2023. PMID: 36925473 Free PMC article. Review.
-
Prospective Advances in Genome Editing Investigation.Adv Exp Med Biol. 2023;1396:301-313. doi: 10.1007/978-981-19-5642-3_19. Adv Exp Med Biol. 2023. PMID: 36454474
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
